ICD-10 codes used to identify adverse drug events in administrative data: a systematic review
暂无分享,去创建一个
Jürgen Stausberg | Corinne M. Hohl | Andrei Karpov | Lisa Reddekopp | J. Stausberg | C. Hohl | A. Karpov | Lisa Reddekopp
[1] K. Hauck,et al. How Dangerous is a Day in Hospital?: A Model of Adverse Events and Length of Stay for Medical Inpatients , 2011, Medical care.
[2] Josip Car,et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005 , 2007, BMC clinical pharmacology.
[3] Analyzing Prescription Drugs as Causes of Death on Death Certificates , 2004, Public health reports.
[4] P. Waller,et al. Comparison of hospital episodes with 'drug-induced' disorders and spontaneously reported adverse drug reactions. , 2006, British journal of clinical pharmacology.
[5] C. Richards,et al. Emergency hospitalizations for adverse drug events in older Americans. , 2011, The New England journal of medicine.
[6] Azeem Majeed,et al. Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009 , 2010, Journal of the Royal Society of Medicine.
[7] Jude L. Michel,et al. A classification of hospital‐acquired diagnoses for use with routine hospital data , 2009, The Medical journal of Australia.
[8] Christel L Burgess,et al. Adverse drug reactions in older Australians, 1981–2002 , 2005, The Medical journal of Australia.
[9] R E Ferner,et al. Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. , 2001, British journal of clinical pharmacology.
[10] D. Bates,et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. , 2003, JAMA.
[11] Jürgen Stausberg,et al. Evaluating adverse drug event reporting in administrative data from emergency departments: a validation study , 2013, BMC Health Services Research.
[12] Jeffrey L. Schnipper,et al. Hospital-Based Medication Reconciliation Practices , 2016 .
[13] A. Shaheen,et al. Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data , 2007, BMC Health Services Research.
[14] F. Chapuis,et al. Heparin-Induced Thrombocytopenia: An Estimate of the Average Cost in the Hospital Setting in France , 2009, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[15] D W Bates,et al. Drugs and adverse drug reactions: how worried should we be? , 1998, JAMA.
[16] R. Raschke,et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital. , 1998, JAMA.
[17] M. Lapeyre-Mestre,et al. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital. , 2006, British journal of clinical pharmacology.
[18] G. Shepherd,et al. Adverse Drug Reaction Deaths Reported in United States Vital Statistics, 1999-2006 , 2012, The Annals of pharmacotherapy.
[19] W. Runciman,et al. A classification for adverse drug events. , 1999, Journal of quality in clinical practice.
[20] L. McKeown,et al. Unintentional and undetermined poisoning deaths--11 states, 1990-2001. , 2004, MMWR. Morbidity and mortality weekly report.
[21] Sebastian Schneeweiss,et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study , 2002, European Journal of Clinical Pharmacology.
[22] P. Barach,et al. Clarifying Adverse Drug Events: A Clinician's Guide to Terminology, Documentation, and Reporting , 2004, Annals of Internal Medicine.
[23] Boris Sobolev,et al. Outcomes of emergency department patients presenting with adverse drug events. , 2011, Annals of emergency medicine.
[24] W. Gaus,et al. Identification of Adverse Drug Reactions by Evaluation of a Prescription Database, Demonstrated for “Risk of Bleeding” , 2005, Methods of Information in Medicine.
[25] P. McKeigue,et al. Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France. , 2008, British journal of clinical pharmacology.
[26] A. Robicsek,et al. 5 Million Lives Campaign , 2008 .
[27] I. Edwards,et al. Adverse drug reactions: definitions, diagnosis, and management , 2000, The Lancet.
[28] E. Bjornsson,et al. The predictors of complications in patients with drug‐induced liver injury caused by antimicrobial agents , 2010, Alimentary pharmacology & therapeutics.
[29] P T Davis. Adverse drug events in hospitalized patients. , 1997, JAMA.
[30] Barbara H. Lang,et al. Epidemiology of Anesthesia-related Mortality in the United States, 1999–2005 , 2009, Anesthesiology.
[31] D. Wysowski,et al. Deaths attributed to X-ray contrast media on U.S. death certificates. , 2006, AJR. American journal of roentgenology.
[32] Identification of Adverse Drug Reactions Using the ICD‐10 Australian Modification Clinical Coding Surveillance , 2009 .
[33] F. Hamada,et al. Acetyl-L-carnitine ameliorates caerulein-induced acute pancreatitis in rats. , 2009, Basic & clinical pharmacology & toxicology.
[34] J. Stausberg,et al. Identification of adverse drug events: the use of ICD-10 coded diagnoses in routine hospital data. , 2010, Deutsches Arzteblatt international.
[35] C. Holman,et al. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study , 2009, BMJ : British Medical Journal.
[36] Jürgen Stausberg,et al. Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data , 2011, BMC health services research.
[37] C. Holman,et al. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. , 2007, British journal of clinical pharmacology.
[38] Stephanie K. Mueller,et al. Hospital-based medication reconciliation practices: a systematic review. , 2012, Archives of internal medicine.
[39] Samy Suissa,et al. Primer: administrative health databases in observational studies of drug effects—advantages and disadvantages , 2007, Nature Clinical Practice Rheumatology.
[40] S. Schroeder,et al. How Many Hours Is Enough? An Old Profession Meets a New Generation , 2004, Annals of Internal Medicine.
[41] D. Wysowski,et al. Surveillance of Prescription Drug-Related Mortality Using Death Certificate Data , 2007, Drug safety.
[42] R S Evans,et al. Computerized surveillance of adverse drug events in hospital patients* , 2005, Quality and Safety in Health Care.
[43] J. Kaltschmidt,et al. Prescribing errors in patients with documented drug allergies: comparison of ICD-10 coding and written patient notes , 2009, Pharmacy World & Science.
[44] P. Ruutu,et al. Hospitalizations and Deaths Associated with Clostridium difficile Infection, Finland, 1996–2004 , 2009, Emerging infectious diseases.
[45] D. Moneret-vautrin,et al. Epidemiology of life‐threatening and lethal anaphylaxis: a review , 2005, Allergy.
[46] Jonathan M. Teich,et al. Research Paper: Identifying Adverse Drug Events: Development of a Computer-based Monitor and Comparison with Chart Review and Stimulated Voluntary Report , 1998, J. Am. Medical Informatics Assoc..
[47] R J Glynn,et al. Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development , 2011, Clinical pharmacology and therapeutics.
[48] M. Afilalo,et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. , 2001, Annals of emergency medicine.
[49] M. Pirmohamed,et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.
[50] A. Egberts,et al. Adverse drug events in hospitalized patients A comparison of doctors, nurses and patients as sources of reports , 1999, European Journal of Clinical Pharmacology.
[51] K. Davison,et al. DRUGS: International Drug Monitoring: The Role of National Centres. , 1973, British Journal of Psychiatry.
[52] P. Noyce,et al. Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies , 2008, The Annals of pharmacotherapy.
[53] D. Levitt. Heterogeneity of human adipose blood flow , 2007, BMC clinical pharmacology.
[54] D. Phillips,et al. A steep increase in domestic fatal medication errors with use of alcohol and/or street drugs. , 2008, Archives of internal medicine.
[55] Catherine M. Dormitzer,et al. Use of parenteral iron products and serious anaphylactic‐type reactions , 2010, American journal of hematology.
[56] Vicki L Burt,et al. Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. , 2010, NCHS data brief.
[57] P. Waller,et al. Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database. , 2005, British journal of clinical pharmacology.
[58] J. Edwards,et al. Extra Adverse drug reactions in hospital patients A systematic review of the prospective and retrospective studies , 2002 .
[59] William B Runciman,et al. Adverse drug events and medication errors in Australia. , 2003, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[60] J. Buechner. Adverse drug reactions in hospital patients. , 1998, Medicine and health, Rhode Island.
[61] Yoon Kim,et al. Evaluation of a computer-based adverse-drug-event monitor. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[62] Katherine E Henson,et al. Risk of Suicide After Cancer Diagnosis in England , 2018, JAMA psychiatry.
[63] J. Brubacher,et al. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study , 2008, Canadian Medical Association Journal.
[64] Chen Wu. Adverse Drug Reactions in the Emergency Department Population in Ontario: Analysis of National Ambulatory Care Reporting System and Discharge Abstract Database 2003-2007 , 2010 .
[65] Richard E Gliklich,et al. GRACE principles: recognizing high-quality observational studies of comparative effectiveness. , 2010, The American journal of managed care.
[66] Scott R. Smith,et al. Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide , 2013 .
[67] Shannon A. Sims,et al. Surveillance of methadone-related adverse drug events using multiple public health data sources , 2007, J. Biomed. Informatics.
[68] D. Wysowski,et al. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. , 2007, Archives of internal medicine.
[69] P. Corey,et al. Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .
[70] D. Classen,et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.